Engineers Gate Manager’s Royalty Pharma RPRX Stock Holding History

Engineers Gate Manager’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.74M	Buy	137,994 +80,771	+141%	+$4.2M	0.1%	225
2026 Q1	$2.74M	Sell	57,223 -60,013	-51%	-$2.63M	0.03%	592
2025 Q4	$4.53M	Buy	+117,236	New	+$4.47M	0.05%	373
2025 Q2	–	Sell	-54,878	Closed	-$1.71M	–	2487
2025 Q1	$1.71M	Buy	54,878 +30,672	+127%	+$972K	0.03%	761
2024 Q4	$617K	Sell	24,206 -64,138	-73%	-$1.7M	0.01%	1298
2024 Q3	$2.5M	Buy	88,344 +38,011	+76%	+$1.05M	0.05%	547
2024 Q2	$1.33M	Sell	50,333 -20,524	-29%	-$569K	0.03%	755
2024 Q1	$2.15M	Sell	70,857 -71,596	-50%	-$2.11M	0.06%	455
2023 Q4	$4M	Buy	142,453 +52,290	+58%	+$1.44M	0.11%	244
2023 Q3	$2.45M	Buy	90,163 +11,843	+15%	+$352K	0.09%	315
2023 Q2	$2.41M	Buy	+78,320	New	+$2.65M	0.09%	297
2023 Q1	–	Sell	-74,880	Closed	-$2.96M	–	1949
2022 Q4	$2.96M	Buy	+74,880	New	+$3.13M	0.18%	111
2022 Q2	–	Sell	-138,281	Closed	-$5.39M	–	2210
2022 Q1	$5.39M	Buy	138,281 +73,870	+115%	+$2.9M	0.21%	89
2021 Q4	$2.57M	Buy	64,411 +20,662	+47%	+$803K	0.12%	209
2021 Q3	$1.58M	Sell	43,749 -70,920	-62%	-$2.76M	0.09%	302
2021 Q2	$4.7M	Buy	114,669 +46,739	+69%	+$1.99M	0.3%	52
2021 Q1	$2.96M	Buy	+67,930	New	+$3.22M	0.15%	145

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Engineers Gate Manager's RPRX Position: Q2 2026 in Review

Engineers Gate Manager increased its Royalty Pharma (RPRX) stake by 141% in Q2 2026, buying an estimated $4.2M and bringing the position to 137,994 shares worth $7.74M. The position accounts for 0.1% of the portfolio, ranked #225.

Engineers Gate Manager first reported a position in RPRX in Q1 2021 and has held it in 17 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Engineers Gate Manager held 137,994 shares of Royalty Pharma worth $7.74M as of Q2 2026.
Engineers Gate Manager bought 80,771 Royalty Pharma shares in Q2 2026, an estimated $4.2M.
Royalty Pharma made up 0.1% of Engineers Gate Manager's portfolio in Q2 2026, its #225 holding.
Engineers Gate Manager first reported a position in Royalty Pharma in Q1 2021 and has held it in 17 quarters since.
641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.